Showing results (1-10 of 452) with videos related to

Sort By:
Pageof 46
Expert Opinion on Biological Therapy|July 28, 2015
Combination therapy for the treatment of Crohn's diseaseMahmoud H Mosli, Brian G Feagan
Expert Opinion on Biological Therapy|February 12, 2013
Vedolizumab for Crohn's diseaseMahmoud H Mosli, Brian G Feagan
Digestive Diseases (Basel, Switzerland)|September 15, 2015
Targeting Leukocyte Trafficking in Inflammatory Bowel Disease: What Is the Clinical Evidence?Reena Khanna, Mahmoud H Mosli, Brian G Feagan
Digestive Diseases (Basel, Switzerland)|March 17, 2016
Anti-Integrins in Ulcerative Colitis and Crohn's Disease: What Is Their Place?Reena Khanna, Mahmoud H Mosli, Brian G Feagan
Digestive Diseases (Basel, Switzerland)|September 14, 2013
Challenging question: is treating inflammatory bowel disease an art or strictly an evidence-based matter?Reena Khanna, Mahmoud H Mosli, Brian G Feagan
Drugs|January 24, 2014
T-cell trafficking and anti-adhesion strategies in inflammatory bowel disease: current and future prospectsMahmoud H Mosli, Jesus Rivera-Nieves, Brian G Feagan
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|August 1, 2015
A Saudi Gastroenterology association position statement on the use of tumor necrosis factor-alfa antagonists for the treatment of inflammatory bowel diseaseMahmoud H Mosli, Othman Al-Harbi, Brian G Feagan, et al.
The American Journal of Gastroenterology|May 21, 2014
Toward a personalized medicine approach to the management of inflammatory bowel diseaseMahmoud H Mosli, William J Sandborn, Richard B Kim, et al.
Inflammatory Bowel Diseases|April 7, 2015
Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysisMahmoud H Mosli, John K MacDonald, Stephen J Bickston, et al.
Pageof 46